Details

Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma
ID Majc, Bernarda (Author), ID Habič, Anamarija (Author), ID Malavolta, Marta (Author), ID Vittori, Miloš (Author), ID Porčnik, Andrej (Author), ID Bošnjak, Roman (Author), ID Mlakar, Jernej (Author), ID Matjašič, Alenka (Author), ID Zupan, Andrej (Author), ID Skoblar Vidmar, Marija (Author), ID Lah Turnšek, Tamara (Author), ID Sadikov, Aleksander (Author), ID Breznik, Barbara (Author), ID Novak, Metka (Author)

.pdfPDF - Presentation file, Download (9,13 MB)
MD5: 8B9E3766305CE4FA5AE6549A934FFB3C
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S2589004224018297 This link opens in a new window

Abstract
Glioblastoma (GB) is the most common primary malignant brain tumor, characterized by resistance to therapy. Despite aggressive treatment options, GB remains an incurable disease. Invasiveness and heterogeneity are key GB features that cannot be studied in preclinical in vitro models. In this study, we investigated the effects of standard therapy using patient-derived GB organoids (GBOs). GBOs reflect the complexity and heterogeneity of the original tumor tissue. No significant effect on GBO viability or invasion was observed after irradiation and temozolomide treatment. E3 ubiquitin-protein ligase (MDM2), cyclin-dependent kinase inhibitor 1A (CDKN1A), and the serine/threonine kinases ATM and ATR were upregulated at the gene and protein levels after treatment. Our results show that the p53 pathway and DNA-damage response mechanisms were triggered, suggesting that GBOs recapitulate GB therapy resistance. GBOs thus provide a highly efficient platform to assess the specific responses of GB patients to therapy and to further explore therapy resistance.

Language:English
Keywords:cellular physiology, cellular toxicology, in vitro toxicology, 3D culture, technical aspects, cell biology, cancer
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FRI - Faculty of Computer and Information Science
BF - Biotechnical Faculty
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:19 str.
Numbering:Vol. 27, iss. 9, art. 110604
PID:20.500.12556/RUL-166746 This link opens in a new window
UDC:576
ISSN on article:2589-0042
DOI:10.1016/j.isci.2024.110604 This link opens in a new window
COBISS.SI-ID:205414147 This link opens in a new window
Publication date in RUL:23.01.2025
Views:597
Downloads:152
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:iScience
Publisher:Elsevier
ISSN:2589-0042
COBISS.SI-ID:24098568 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:glioblastom, organoidi, monoterpeni, rak, onkologija, celična fiziologija, celična toksikologija, celična biologija, toksikologija in vitro

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0245
Name:Ekotoksiologija, toksikološka genomika in karcinogeneza

Funder:ARRS - Slovenian Research Agency
Project number:J3-4504
Name:Z vizualizacijo mikrookolja glioblastoma do boljše terapije

Funder:ARRS - Slovenian Research Agency
Project number:J3-2526
Name:Razkrivanje niše matičnih glioma celic v iskanju novih terapevtskih ciljev pri bolnikih z glioblastomom

Funder:ARRS - Slovenian Research Agency
Project number:NC-0023
Name:Inovativne sonde in inhibicija metaloproteaz za ciljanje glioblastomskih matičnih celic v tumorskem mikrookolju

Funder:ARRS - Slovenian Research Agency
Funding programme:Young researchers
Project number:10040137

Funder:ARRS - Slovenian Research Agency
Funding programme:Younger researcher
Project number:10040147

Funder:EC - European Commission
Funding programme:Interreg Slovenia-Italy
Acronym:TRANS-GLIOMA

Funder:EC - European Commission
Funding programme:HE
Project number:101079113
Name:Twinning for excellence to strategically advance research in carcinogenesis and cancer
Acronym:CutCancer

Funder:EC - European Commission
Funding programme:H2020
Project number:956394
Name:PremAtuRe nEwborn motor and cogNitive impairmenTs: Early diagnosis
Acronym:PARENT

Funder:ARRS - Slovenian Research Agency
Project number:P2-0209
Name:Umetna inteligenca in inteligentni sistemi

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back